Khiron Life Sciences Corp.
KHRNH.V
TSX
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -3.45% | 56.44% | 1.49% | -748.99% | 47.44% |
| Total Depreciation and Amortization | 57.41% | 93.35% | 100.68% | -71.46% | 249.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.35% | -372.53% | 583.85% | 520.23% | -193.40% |
| Change in Net Operating Assets | -88.42% | -45.21% | 110.83% | 141.45% | -233.54% |
| Cash from Operations | -0.34% | 12.00% | 65.80% | 7.11% | -5.52% |
| Capital Expenditure | -288.69% | -26.43% | -188.03% | -56.09% | 31.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -324.77% | -- | -- | 22,300.00% | -- |
| Cash from Investing | -293.35% | -57.26% | -180.78% | -98.42% | 21.12% |
| Total Debt Issued | 310.65% | -- | -- | -- | -- |
| Total Debt Repaid | 101.19% | 56.43% | -21.69% | 401.08% | 196.00% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.07% | -- | -- | 841.09% | -- |
| Cash from Financing | -92.47% | 695.72% | 22.08% | -96.17% | 13,483.11% |
| Foreign Exchange rate Adjustments | 1,019.45% | -375.58% | 16.81% | -513.16% | -123.43% |
| Miscellaneous Cash Flow Adjustments | -100.56% | -- | -- | -99.86% | 125.56% |
| Net Change in Cash | -161.74% | 121.11% | 58.48% | -197.31% | 218.15% |
